Europe is experiencing delays in supplies of medicines and face masks because of coronavirus disruptions, according to EU and industry officials, compounding already acute shortages of drugs on the continent.
BRUSSELS: Europe is experiencing delays in supplies of medicines and face masks because of coronavirus disruptions, according to EU and industry officials, compounding already acute shortages of drugs on the continent.
Many countries around the world rely on China, the source of the outbreak, for drug ingredients in an age of global supply chains, and are grappling with how to avoid shortages of vital medicines.
The European Union is assessing the delays in drug shipments from Asia, a senior official from the EU Commission said, as France warned it was over-dependent on China with about 40 per cent of the country’s drug ingredients imported from there.
The European concerns come as India, which is the world’s main supplier of generic medicines and also relies on Chinese ingredients, decided to restrict some drug exports.
READ: Protective gear to fight COVID-19 ‘rapidly depleting’: WHO
“Many active pharmaceutical ingredients are produced in China and the virus outbreak is affecting the manufacturing capacity and stability of the supply of these ingredients,” the European Medicines Agency, an EU body, told Reuters.
“This could potentially lead to shortages of medicines worldwide.”
The Commission, the EU’s executive arm, said it had not yet seen shortages in the bloc caused by the virus. But any hit to supplies due to the outbreak could worsen existing shortfalls.
NEEDED: FACE MASKS
A survey of 24 EU countries at the end of last year found all had experienced shortages of medicines in 2019, while the number of drugs in short supply grew in most states, according to the Pharmaceutical Group of the European Union (PGEU), a trade body.
Respiratory medications were not sufficiently available in nearly all surveyed states, the report found, raising worries about the EU’s preparedness for a large outbreak of coronavirus, which can cause pneumonia and other breathing illnesses.
Jan De Belie of the PGEU said that, as well as China, Europe could face supply problems from northern Italy, a region where many drug producers operate and which has suffered the worst outbreak of the new coronavirus outside Asia.
EU officials also warn the bloc is running short of face masks and other personal protective gear because of soaring demand, particularly in Italy.
Last week, the Commission launched a joint procurement effort on behalf of 20 EU states. But officials said that even if they could secure supplies, they were unlikely to be delivered before April.
“There is a shortage in the market for these products,” a Commission official told EU lawmakers in a hearing on Thursday. “We will have difficulty in meeting all the anticipated needs of member states.”